Transscleral iontophoretic and intravitreal delivery of a macromolecule: Study of ocular distribution in vivo and postmortem with MRI

Experimental Eye Research

Volumn 88, Issue 3, 2009, Pages 418-425

  Molokhia, Sarah A ^a   Jeong, Eun Kee ^b   Higuchi, William I ^a   Li, S Kevin ^c  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

drug delivery; intravitreal injection; iontophoresis; MRI; ocular; pharmacokinetics

Indexed keywords

GADOLINIUM PENTETATE ALBUMIN;

ANIMAL EXPERIMENT; AQUEOUS HUMOR; ARTICLE; CADAVER; CHOROID; CONJUNCTIVA; CONTROLLED STUDY; FLAME PHOTOMETRY; IN VIVO STUDY; IONTOPHORESIS; MACROMOLECULE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETINA; SCLERA; VITREOUS BODY;

ANIMALS; DRUG DELIVERY SYSTEMS; EYE; IONTOPHORESIS; MACROMOLECULAR SUBSTANCES; MAGNETIC RESONANCE IMAGING; RABBITS; SCLERA; VITREOUS BODY;

EID: 61549127583     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2008.10.010     Document Type: Article

References (40)

1. Antcliff R.J., Spalton D.J., Stanford M.R., Graham E.M., ffytche T.J., and Marshall J. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 108 (2001) 765-772
2. Berkowitz B.A., Wilson C.A., Tofts P.S., and Peshock R.M. Effect of vitreous fluidity on the measurement of blood-retinal barrier permeability using contrast-enhanced MRI. Magn. Reson. Med. 31 (1994) 61-66
3. Cantor C.R., and Schimmel P.R. Biophysical Chemistry: Part II: Techniques for the Study of Biological Structure and Function. first ed. (1980), W.H. Freeman
4. Eljarrat-Binstock E., Domb A.J., Orucov F., Frucht-Pery J., and Pe'er J. Methotrexate delivery to the eye using transscleral hydrogel iontophoresis. Curr. Eye Res. 32 (2007) 639-646
5. Eljarrat-Binstock E., Orucov F., Frucht-Pery J., Pe'er J., and Domb A.J. Methylprednisolone delivery to the back of the eye using hydrogel iontophoresis. J. Ocul. Pharmacol. Ther. 24 (2008) 344-350
6. Eljarrat-Binstock E., Raiskup F., Stepensky D., Domb A.J., and Frucht-Pery J. Delivery of gentamicin to the rabbit eye by drug-loaded hydrogel iontophoresis. Investig. Ophthalmol. Vis. Sci. 45 (2004) 2543-2548
7. Gilger B.C., Salmon J.H., Wilkie D.A., Cruysberg L.P., Kim J., Hayat M., Kim H., Kim S., Yuan P., Lee S.S., Harrington S.M., Murray P.R., Edelhauser H.F., Csaky K.G., and Robinson M.R. A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis. Investig. Ophthalmol. Vis. Sci. 47 (2006) 2596-2605
8. Haupert C.L., and Jaffe G.J. New and emerging treatments for patients with uveitis. Int. Ophthalmol. Clin. 40 (2000) 205-220
9. Iturralde D., Spaide R.F., Meyerle C.B., Klancnik J.M., Yannuzzi L.A., Fisher Y.L., Sorenson J., Slakter J.S., Freund K.B., Cooney M., and Fine H.F. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 26 (2006) 279-284
10. Kamei M., Misono K., and Lewis H. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. Am. J. Ophthalmol. 128 (1999) 739-746
11. Kim H., Robinson M.R., Lizak M.J., Tansey G., Lutz R.J., Yuan P., Wang N.S., and Csaky K.G. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging. Investig. Ophthalmol. Vis. Sci. 45 (2004) 2722-2731
12. Kim S.H., Csaky K.G., Wang N.S., and Lutz R.J. Drug elimination kinetics following subconjunctival injection using dynamic contrast-enhanced magnetic resonance imaging. Pharm. Res. 25 (2008) 512-520
13. Kim S.H., Galban C.J., Lutz R.J., Dedrick R.L., Csaky K.G., Lizak M.J., Wang N.S., Tansey G., and Robinson M.R. Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging. Investig. Ophthalmol. Vis. Sci. 48 (2007) 808-814
14. Kondo M., and Araie M. Iontophoresis of 5-fluorouracil into the conjunctiva and sclera. Investig. Ophthalmol. Vis. Sci. 30 (1989) 583-585
15. Kralinger M.T., Voigt M., Kieselbach G.F., Hamasaki D., Hayden B.C., and Parel J.M. Ocular delivery of acetylsalicylic acid by repetitive coulomb-controlled iontophoresis. Ophthalmic Res. 35 (2003) 102-110
16. Lam T.T., Edward D.P., Zhu X.A., and Tso M.O. Transscleral iontophoresis of dexamethasone. Arch. Ophthalmol. 107 (1989) 1368-1371
17. Lang J.C. Ocular drug delivery conventional ocular formulations. Adv. Drug Deliv. Rev. 16 (1995) 39-43
18. Li S.K., Jeong E.K., and Hastings M.S. Magnetic resonance imaging study of current and ion delivery into the eye during transscleral and transcorneal iontophoresis. Investig. Ophthalmol. Vis. Sci. 45 (2004) 1224-1231
19. Li S.K., Molokhia S.A., and Jeong E.K. Assessment of subconjunctival delivery with model ionic permeants and magnetic resonance imaging. Pharm. Res. 21 (2004) 2175-2184
20. Los L.I. The rabbit as an animal model for post-natal vitreous matrix differentiation and degeneration. Eye 22 (2008) 1223-1232
21. Marmor M.F., Negi A., and Maurice D.M. Kinetics of macromolecules injected into the subretinal space. Exp. Eye Res. 40 (1985) 687-696
22. Maurice D.M. Protein dynamics in the eye studied with labelled proteins. Am. J. Ophthalmol. 47 (1959) 361-368
23. Maurice D.M. Review: practical issues in intravitreal drug delivery. J. Ocul. Pharmacol. Ther. 17 (2001) 393-401
24. McLennan D.N., Porter C.J.H., and Charman S.A. Subcutaneous drug delivery and the role of the lymphatics. Drug Discov. Today: Technol. 2 (2005) 89-96
25. Miller D.J., Li S.K., Tuitupou A.L., Kochambilli R.P., Papangkorn K., Mix D.C.J., Higuchi W.I., and Higuchi J.W. Passive and oxymetazoline-enhanced delivery with a lens device: pharmacokinetics and efficacy studies with rabbits. J. Ocul. Pharm. Ther 24 (2008) 385-391
26. Mitra A.K. Ophthalmic Drug Delivery Systems. second ed. (2003), Marcel Dekker, New York
27. Molokhia S.A., Jeong E.K., Higuchi W.I., and Li S.K. Examination of penetration routes and distribution of ionic permeants during and after transscleral iontophoresis with magnetic resonance imaging. Int. J. Pharm. 335 (2007) 46-53
28. Molokhia S.A., Jeong E.K., Higuchi W.I., and Li S.K. Examination of barriers and barrier alteration in transscleral iontophoresis. J. Pharm. Sci. 97 (2008) 831-844
29. Parkinson T.M., Ferguson E., Febbraro S., Bakhtyari A., King M., and Mundasad M. Tolerance of ocular iontophoresis in healthy volunteers. J. Ocul. Pharmacol. Ther. 19 (2003) 145-151
30. Peyman G.A., and Bok D. Peroxidase diffusion in the normal and laser-coagulated primate retina. Investig. Ophthalmol. 11 (1972) 35-45
31. Robinson M.R., Lee S.S., Kim H., Kim S., Lutz R.J., Galban C., Bungay P.M., Yuan P., Wang N.S., Kim J., and Csaky K.G. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide. Exp. Eye Res. 82 (2006) 479-487
32. Smelser G.K., Ishikawa T., and Pei Y.F. Structure of the Eye (1965), Schattauer-Verlag, Stuttgart
33. Supersaxo A., Hein W.R., and Steffen H. Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration. Pharm. Res. 7 (1990) 167-169
34. Urtti A. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv. Drug Deliv. Rev. 58 (2006) 1131-1135
35. Voigt M., Kralinger M., Kieselbach G., Chapon P., Anagnoste S., Hayden B., and Parel J.M. Ocular aspirin distribution: a comparison of intravenous, topical, and coulomb-controlled iontophoresis administration. Investig. Ophthalmol. Vis. Sci. 43 (2002) 3299-3306
36. Vollmer D.L., Szlek M.A., Kolb K., Lloyd L.B., and Parkinson T.M. In vivo transscleral iontophoresis of amikacin to rabbit eyes. J. Ocul. Pharmacol. Ther. 18 (2002) 549-558
37. Worakul N., and Robinson J.R. Ocular pharmacokinetics/pharmacodynamics. Eur. J. Pharm. Biopharm. 44 (1997) 71-83
38. Wu J.C., Jesmanowicz A., and Hyde J.S. Anterior segment high resolution MRI: aqueous humor dynamics observed using contrast agents. Exp. Eye Res. 54 (1992) 145-148
39. Xu J., Heys J.J., Barocas V.H., and Randolph T.W. Permeability and diffusion in vitreous humor: implications for drug delivery. Pharm. Res. 17 (2000) 664-669
40. Yoo S.H., Dursun D., Dubovy S., Miller D., Alfonso E., Forster R.K., Behar-Cohen F., and Parel J.M. Iontophoresis for the treatment of paecilomyces keratitis. Cornea 21 (2002) 131-132